Skip to content

Clinicopathological characteristics and prognostic factors of primary pancreatic ductal adenocarcinoma

Clinicopathological characteristics and prognostic factors of primary pancreatic ductal adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096554
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary pancreatic ductal adenocarcinoma

Interventions

Case series:Test group

Sponsors

The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The primary lesion is located in the pancreas. 2. The diagnosis is confirmed by pathology as pancreatic ductal adenocarcinoma. 3. A clear record of each patient's medical history, including symptoms, diagnosis, treatment methods, and prognosis, is available. 4. Patients voluntarily sign the informed consent form and are able to complete the follow-up plan.

Exclusion criteria

Exclusion criteria: 1. Patients with non-primary pancreatic ductal adenocarcinoma. 2. Individuals lacking legal capacity or self-awareness. 3. Patients who refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
Overall Survival;

Secondary

MeasureTime frame
Progression free survival;disease control rate;Objective relief rate;

Countries

China

Contacts

Public ContactWang Wei

The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

ww.wwj@163.com+86 180 1756 1386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026